Screening and Diagnosis

You can find patients with OUD to treat with MOUD in your practice and by establishing a referral base in your community. Screening for opioid misuse and diagnosing OUD can help patients in need get access to treatment. You may already update your patients' current medications and substance use at each visit as part of standard practice, otherwise Early in the treatment process, conduct a comprehensive screening so you can tailor treatment to the patient's needs and circumstances. However, only the essential screening and assessment should occur before starting patients on medication.

The practice systematically and proactively identifies which patients can likely benefit from treatment with medications for OUD using standardized tools or screening instruments.

The practice identifies the patient's particular needs, preferences, and barriers to OUD treatment. Medications are started as soon as safely possible. As time allows, complete a more comprehensive assessment that can be used to inform customized treatment plans developed through shared decision-making.

Many of the patients you treat with MOUD may come from outside referrals. You can cultivate a relationship with providers and organizations in your community which, combined with the low threshold quick access to appointments and medications, may be more effective than screening for patients in your practice.1 See Care Coordination and Patient Referral Sources for more information.

Screen patients who report opioid use to assess for misuse and to determine which of your patients uses non-prescribed opioids. This may already be part of your standard practice of updating their list of medications and other substances used. This can be done through clinical discussions or by using a validated screening tool.

Ideally, decide which standardized screening tools to use and determine how to incorporate screening into your patient workflow. These tools may be self-administered online or on paper, or they may be administered by staff. For tools requiring staff administration, it may be more efficient to have nurses or clinical assistants handle the process. Many of these screeners also detect other substances with misuse potential. Selected screening tools are listed under the Resources section.

Symptoms of opioid misuse include:

Determine which patients meet criteria for a diagnosis of OUD, based on the Diagnostic and Statistical Manual for Mental Disorders, Fifth Edition (DSM-5). The following brief criteria or a worksheet such as the DSM-5 Criteria for Diagnosis of Opioid Use Disorder (PDF - 101 KB) may help.

  • Taking more, or for longer than intended;
  • Inability to reduce use;
  • Spending a lot of time procuring, using, or recovering from the effects;
  • Craving;
  • Failing obligations;
  • Social problems due to use;
  • Choosing over recreation or work;
  • Using in physically hazardous situations;
  • Using despite related physical or psychological problems;
  • Tolerance;* and
  • Withdrawal.*

* Note that tolerance and withdrawal do not count toward the diagnosis for people who only take opioids as prescribed, under direct medical care.2

Severity indicators for OUD are as follows:

  • Two to three criteria have a mild OUD;
  • Four to five criteria have a moderate OUD; and
  • Six or more criteria have a severe OUD.

A comprehensive assessment of a patient's needs, including what is important to them that they hope to get from OUD treatment, will help you plan and tailor treatment for each patient. Do not delay buprenorphine simply to complete assessments. Be aware of requirements of payers you are working with, such as the need to demonstrate medical necessity for prior authorization. When assessment is completed will depend on your practice and the patient's situation. It may be completed at intake, once the patient has been stabilized on medication, or over time.

At a minimum, the assessment should include:

  • Ability to participate in treatment: Potential barriers to treatment continuation (e.g., scheduling of appointments, transportation, and childcare); OUD triggers and life stressors; and personal support systems.
  • Considerations for decision-making: Goals for life and treatment; patient concerns and preferences about medications for OUD; and any prior use of medications for OUD and their reason for discontinuation.
  • Basic medical information: List of current medications and associated allergies; current opioid use and co-occurring substance use; and medical, mental health, and substance use histories.

As with many patients living with a chronic condition, individuals with OUD often have complex needs. Even if your practice cannot address all the patient's treatment needs, screening can help you understand the patient's needs more fully so you can connect them with appropriate care or even refer them to a higher level of care.

Screening for mental health needs, such as anxiety and depression, is recommended by the U.S. Preventive Services Taskforce,5 and may be more informative than simply asking the patient. Common co-occurring disorders with SUD and screening tools are as follows:

For patients who screen positive for mental health symptoms, consider referring them for Counseling and Other Psychosocial Supports and, if indicated, prescribing psychiatric medications.

Health-related social needs (HRSNs), including employment, housing, food, safety, and transportation are essential to health and wellbeing. Patients with unmet HRSNs will have more difficulty engaging with treatment until those needs are met. Consider using a screener6 for HRSN such as A Guide to Using the Accountable Health Communities Health-Related Social Needs Screening Tool: Promising Practices and Key Insights (PDF - 796 KB) or the Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences (PRAPARE).

Anything you can do to identify patients with unmet HRSN and help them address these needs will improve the likelihood of successful treatment for OUD or any other chronic condition.7 The North Star approach would be to identify patients with unmet HRSN and link them with appropriate community resources by doing a warm handoff to the organization and/or to have a closed loop referral, so you know the connection was made when tracking the results.

On the other hand, addressing a patient's HRSNs directly is probably beyond the scope of primary care, and just providing the patient with a printed referral list is probably insufficient to address their HRSN. Depending on the scope of your practice, patients with unmet HRSNs may be too complex to serve in primary care and may need a higher level of care to treat their OUD.

Consider screening for other needs common among people with OUD such as:

Depending on the patient and your practice, you may wish to assess these or refer patients for additional or a higher level of care.

  • Don't rely on clinician impressions, outside referrals, or patient disclosure as your only methods for identifying patients who could benefit from MOUD.
  • Don't allow comprehensive screening and assessments at intake to delay patients' access to medications for OUD.
  • Don't assume patient needs will stay the same throughout the course of treatment. Conduct periodic assessments to help inform adjustments and updates to the treatment plan.

Screening, Brief Intervention, Referral to Treatment (SBIRT) for Substance Use Disorders in Primary Care Settings

This module discusses the Screening, Brief Intervention, Referral to Treatment (SBIRT) model and approved treatments for substance use treatment. Different screening tools are also provided.
Format
Web-Based Course
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Source
Provider Clinical Support System (PCSS)
Year
Resource Type
Web Page

The Primary Care PTSD Screen for DSM-5 (PC-PTSD-5)

Offers a 5-item screen that was designed for use in primary care and other medical settings and is currently used to screen for post-traumatic stress disorder (PTSD) in veterans using VA healthcare. Includes an introductory sentence to cue respondents to traumatic events but does not include a list of potentially traumatic events.
Format
Instrument/Protocol
Audience
Medical Providers
Behavioral Health Providers
Source
Prins A, et al.
Year

1. Fortney JC, Ratzliff AD, Blanchard BE, et al. Does Screening for Opioid Use Disorder in Primary Care Increase the Percentage of Patients with a New Diagnosis? Ann Intern Med. 2023;176(10). doi:10.7326/M23-1369

2. CDC. Opioid Use Disorder: Diagnosis. Overdose Prevention. May 7, 2024. Accessed May 29, 2025. https://www.cdc.gov/overdose-prevention/hcp/clinical-care/opioid-use-disorder-diagnosis.html

3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). Published online 2022. doi:https://doi.org/10.1176/appi.books.9780890425787

4. Substance Abuse and Mental Health Services Administration. TIP 63: Medications for Opioid Use Disorder. SAMHSA; 2021. Accessed April 7, 2025. https://library.samhsa.gov/product/tip-63-medications-opioid-use-disorder/pep21-02-01-002

5. United States Preventive Services Taskforce. Home page | United States Preventive Services Taskforce. Accessed June 3, 2025. https://www.uspreventiveservicestaskforce.org/uspstf/

6. National Association of Community Health Centers. Protocol for Responding to and Assessing Patient Assets, Risks, and Experiences. Published online 2016. Accessed April 25, 2025. https://prapare.org/wp-content/uploads/2023/01/PRAPARE-English.pdf

7. Centers for Medicare and Medicaid Services. A Guide to Using the Accountable Health Communities Health-Related Social Needs Screening Tool. CMS; 2023. Accessed April 24, 2025. https://www.cms.gov/priorities/innovation/media/document/ahcm-screeningtool-companion?utm_source=chatgpt.com

8. Smith PC, Schmidt SM, Allensworth-Davies D, Saitz R. A Single-Question Screening Test for Drug Use in Primary Care. Arch Intern Med. 2010;170(13). doi:10.1001/archinternmed.2010.140

9. Weathers, F. W., Litz, B. T, Keane, T. M., Palmieri, P. A., Marx, B. P, Schnurr, P. P. The PTSD Checklist for DSM-5 (PCL-5) — Standard [Measurement instrument]. Published online 2023. Accessed May 29, 2025. https://www.ptsd.va.gov/professional/assessment/documents/PCL5_Standard_form.PDF